Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 mRNA flu shots move into trials.

Literature DB >> 34635829

mRNA flu shots move into trials.

Elie Dolgin.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34635829 DOI： 10.1038/d41573-021-00176-7

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Generation of a live attenuated influenza A vaccine by proteolysis targeting.

Authors: Longlong Si; Quan Shen; Jing Li; Li Chen; Jinying Shen; Xue Xiao; Haiqing Bai; Tang Feng; Adam Yongxin Ye; Le Li; Chunhe Zhang; Zhen Li; Ping Wang; Crystal Yuri Oh; Atiq Nurani; Siwen Niu; Chengxin Zhang; Xiaoqiong Wei; Wanqiong Yuan; Hao Liao; Xiaojie Huang; Ning Wang; Wen-Xia Tian; Hongwei Tian; Li Li; Xiaoheng Liu; Roberto Plebani
Journal: Nat Biotechnol Date: 2022-07-04 Impact factor: 68.164

2. Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.

Authors: Angus Forster; Michael Junger
Journal: Hum Vaccin Immunother Date: 2022-03-31 Impact factor: 4.526

Review 3. Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies.

Authors: Gautam Sanyal
Journal: NPJ Vaccines Date: 2022-05-05 Impact factor: 9.399

mRNA flu shots move into trials.

1. Generation of a live attenuated influenza A vaccine by proteolysis targeting.

2. Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.

Review 3. Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies.

Review 4. Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience.

Review 5. Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.

Review 6. Universal Flu mRNA Vaccine: Promises, Prospects, and Problems.

7. Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants.

8. Universal flu vaccines: a shot at lifelong cardioprotection?

Review 9. COVID-19 mRNA vaccines: Platforms and current developments.

10. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination.